CIK 0001802768 · Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- (212) 883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,324,753
- in 4 filings, $12.3M under 10b5-1 plans
Net −$12,324,753. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-11 | Norden Gregory Director | Sale | −33,500 | $36.23 | $1.2M | 194,848 |
| 2025-08-08 | Norden Gregory Director | Conversion | +144,660 | 228,348 | ||
| 2025-08-08 | Norden Gregory Director | Conversion · LP interests in RPI US Partners 2019, LP | −14,466 | 0 | ||
| 2025-08-08 | Legorreta Pablo G. CEO, Chairman of the Board | Gift · LP interests in RPI US Partners 2019, LP | −60,000 | 692,701 | ||
| 2025-08-08 | Coyne Terrance P. EVP & CFO | Gift · LP interests in RPI US Partners 2019, LP | −1,000 | 43,350 | ||
| 2025-08-08 | Lloyd George W. EVP, Investments & CLO | Gift · LP interests in RPI US Partners 2019, LP | −8,500 | 0 | ||
| 2025-08-08 | Urist Marshall EVP, Research & Investments | Gift · LP interests in RPI US Partners 2019, LP | −3,000 | 263,412 | ||
| 2025-08-06 | Legorreta Pablo G. CEO, Chairman of the Board | Grant or award | +21,901 | 904,396 | ||
| 2025-08-06 | Coyne Terrance P. EVP & CFO | Grant or award | +3,696 | 52,342 | ||
| 2025-08-06 | Lloyd George W. EVP, Investments & CLO | Grant or award | +3,696 | 52,342 | ||
| 2025-08-06 | Hite Christopher EVP & Vice Chairman | Grant or award | +3,696 | 652,342 | ||
| 2025-08-06 | Urist Marshall EVP, Research & Investments | Grant or award | +2,772 | 39,256 | ||
| 2025-07-31 | WEATHERMAN ELIZABETH H Director | Grant or award | +2,752 | 2,752 | ||
| 2025-07-31 | WEATHERMAN ELIZABETH H Director | Grant or award | +5,806 | 8,558 | ||
| 2025-07-31 | Ho Carole Director | Grant or award | +2,752 | 2,752 | ||
| 2025-07-31 | Ho Carole Director | Grant or award | +5,806 | 8,558 | ||
| 2025-06-30 | Fernandez Henry A Director | Grant or award | +1,064 | $35.24 | $37K | 65,324 |
| 2025-06-30 | Bassler Bonnie L Director | Grant or award | +1,064 | $35.24 | $37K | 71,118 |
| 2025-05-16 | Hite Christopher EVP & Vice Chairman | Grant or award · Class E Ordinary Shares | +1,238,789 | 1,238,789 | ||
| 2025-05-16 | Urist Marshall EVP, Research & Investments | Grant or award · Class E Ordinary Shares | +1,356,528 | 1,356,528 |
Page 7 of 8 · 159 trades